Atrion (ATRI) Stock Rating Upgraded by BidaskClub
BidaskClub upgraded shares of Atrion (NASDAQ:ATRI) from a hold rating to a buy rating in a research note published on Friday.
Shares of NASDAQ ATRI opened at $653.00 on Friday. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 34.99 and a beta of 0.64. Atrion has a 1 year low of $516.85 and a 1 year high of $694.25.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Stockholders of record on Friday, September 14th will be paid a dividend of $1.35 per share. This represents a $5.40 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Thursday, September 13th. This is an increase from Atrion’s previous quarterly dividend of $1.20.
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Featured Story: Price to Earnings Ratio (PE)
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.